Carlyle has sold Tescan, a manufacturer of electron microscopes and scientific instruments, for $850 million. The firm’s investment yielded a notable EBITDA boost for the Czech-based company. This exit marks a successful outcome for the private equity firm, which had backed Tescan’s growth in the competitive scientific tools market.

The deal underscores private equity’s interest in industrial technology and precision manufacturing. Tescan’s instruments are critical for materials science and semiconductor research. Carlyle’s strategy focused on scaling operations and improving profitability, a common playbook for PE firms in specialized, high-margin sectors.

A buyer for Tescan was not named in the initial report. The transaction likely attracted strategic industrial firms or other PE players. Investors will watch for the final multiple and how the proceeds are deployed by Carlyle. The sale also highlights the ongoing consolidation in the global laboratory equipment industry.